Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells

Biochemical and Biophysical Research Communications

Volumn 281, Issue 2, 2001, Pages 361-366

  Makiishi Shimobayashi, Chiaki ^a   Tsujimura, Tohru ^a   Iwasaki, Teruo ^a   Yamada, Naoko ^a   Sugihara, Ayako ^a   Okamura, Haruki ^a   Hayashi, Shin ichi ^b   Terada, Nobuyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Interleukin 18; MC3T3 E1 cell; Osteoblast; Osteoclast differentiation factor; Osteoclastogenesis; Osteoprotegerin; ST2 cell

Indexed keywords

ADAPTOR PROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0034817134     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4380     Document Type: Article

References (32)

1. Cell biology of the osteoclast
2. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
3. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
4. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
5. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
6. Interleukin-18: A novel cytokine that augments both innate and acquired immunity
7. Interleukin-18: Biological properties and clinical implications
8. Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation
9. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulationg factor
10. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
11. INF-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones
12. Osteoblastic cells are involved in osteoclast formation
13. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
14. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA
15. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
16. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling
17. Nucleotide sequence and expression of a cDNA encoding Myd88, a novel myeloid differentiation primary response gene induced by IL-6
18. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
19. Purification and characterization of the human interleukin-18 receptor
20. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
21. Interleukin-18 induces activation and association of p561ck and MAPK in a murine TH1 clone
22. erk-21
23. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
24. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
25. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation
26. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
27. Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
28. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: Modulation of the expression by osteotropic factors and cytokines
29. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-γ production
30. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function
31. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
32. Defective interleukin (IL)-18-mediated natural killer and T helper cell type I responses in IL-1 receptor-associated kinase (IRAK)-deficient mice